good's syndrome complicated with covid-19 and recurrent pulmonary infections: a case report

Good's syndrome (gs), a rare immunodeficiency disorder characterized by thymoma and hypogammaglobulinemia, presents diagnostic and therapeutic challenges due to recurrent infections.we report a 53-year-old male farmer with gs complicated by recurrent pulmonary infections and covid-19. initial management focused on antiviral/anti-infective therapy and corticosteroids, but persistent hypogammaglobulinemia, b-cell depletion, and thymoma history were overlooked.diagnosis was confirmed upon integrating the thymoma history, immunological profiling, and bronchial alveolar lavage-next generation sequencing, revealing pneumocystis jirovecii and herpes simplex virus-1 coinfections. treatment with intravenous immunoglobulin loading dose (2 g/kg), pathogen-targeted therapy (voriconazole, cotrimoxazole), and tapered corticosteroids achieved clinical remission, with immunoglobulin g (igg) elevating to 6.35 g/l.this case underscores the necessity of a four-dimensional early warning system integrating thymoma history, immune, imaging, and pathogen for timely gs diagnosis. multidisciplinary collaboration and personalized regimens combining immunoglobulin replacement, precision anti-infectives, and immunomodulation are pivotal for optimizing outcomes in gs patients with complex infections.